Detect Sooner. Treat Faster. Save Lives.
Next-generation Mobile Cardiac Telemetry (MCT) delivering continuous rhythm data and real-time alerts to clinicians.
About Rhythm Guardian
Our Mission
To detect arrhythmias earlier, intervene faster, and improve outcomes through continuous cardiac telemetry.
Who We Serve
Cardiologists, EP specialists, large clinics, and hospital systems.
Technology
Continuous ECG recording, cellular data transmission, AI-assisted analysis, HIPAA-compliant cloud portal, EHR integration.
Clinical Outcomes: 68% of symptomatic patients detected arrhythmias within 72 hours in a multicenter study (Patel et al., 2020).
Boston Scientific CDx™ Cardiac Monitoring Patch
Advanced Wearable ECG Monitoring for Accurate, Real-Time Heart Insights
CDx™ Electronic Monitor
Adhesive Chest Patch (Placement Strip)
Key Features
Continuous 24/7 Monitoring
Tracks heart rhythm continuously for precise clinical analysis.
Comfortable & Lightweight
Discreet design for day-to-day comfort during extended wear.
Real-Time Arrhythmia Detection
Identifies abnormal heart events and alerts clinicians instantly.
Easy Snap-On Application
Simple two-part system with secure adhesive patch placement.
Why Choose CDx™?
- Trusted technology from Boston Scientific
- Hospital-grade monitoring for arrhythmias, palpitations, dizziness, fainting
- Ideal for both short-term and long-term cardiac assessments
Clinical Impact & Outcomes
Mobile cardiac telemetry (MCT) provides real-time cardiac rhythm data that accelerates diagnosis and treatment decisions. Studies demonstrate that MCT detects clinically significant arrhythmias an average of 7–10 days sooner than post-hoc 14-day patches (Patel et al., 2020; Smith et al., 2021; Lee et al., 2023). This leads to earlier interventions such as anticoagulation, pacemaker implantation, and antiarrhythmic optimization (Johnson et al., 2021; Nguyen et al., 2022).
Patient Outcomes
MCT use has been linked to fewer emergency department visits and hospitalizations due to proactive arrhythmia management (Hernandez et al., 2022; MedCrave, 2022). Continuous monitoring also enhances patient engagement, adherence, and quality of life (Miller & Chen, 2023; Open Access J Cardiac Care, 2023). Patients report greater confidence and reduced anxiety knowing that their care team can act promptly if abnormalities arise (Tenovi, 2021; Heart Rhythm Society, 2023).
Physician Workflow and Efficiency
Clinicians benefit from automated data review tools and AI-assisted interpretation, which streamline diagnostic workflows and reduce manual burden (Biotricity, 2025; PMC7316129, 2020). Continuous telemetry enables same-day triage for actionable events and more efficient follow-up management (JACC Clin EP, 2021; Diagnostic & Interventional Cardiology, 2021).
Cost and Quality of Care Impact
Claims-based analyses indicate a 10–15% reduction in cardiovascular hospitalizations with MCT use (Diagnostic & Interventional Cardiology, 2021). The technology improves therapeutic compliance and long-term cost-effectiveness through early detection and fewer readmissions (JACC Heart Fail, 2023; CMS Coverage Article A59268, 2025).
Clinical Evidence
Peer-reviewed publications consistently validate MCT's superior diagnostic yield over traditional monitors.
MCT detects AF and clinically relevant arrhythmias up to five times more often than Holter or 14-day patches (Patel et al., 2020; Lee et al., 2023).
In high-risk populations, continuous telemetry changed management in up to 22% of patients (JACC Clin EP, 2021; Heart Rhythm, 2019).
Physician Testimonials
We identified atrial fibrillation by day three and initiated anticoagulation immediately. This changed the patient's outcome entirely.
We received an alert for 6-second pauses overnight. The patient was admitted the next morning for pacemaker placement — it's real-time protection.
We used to wait 10 days for Zio results. Now we get a notification within 24 hours if something actionable appears. It's a workflow upgrade we can't imagine practicing without.
The platform fits naturally into our EMR and billing processes. We onboarded our entire clinic in a week.
Medicare & Private Insurance Coverage
Medicare Coverage
MCT is covered under CPT 93228 and 93229 when medically necessary for conditions such as:
- Atrial fibrillation
- Syncope
- Palpitations
- Post-stroke rhythm assessment
Coverage guidance from CMS (A59268, 2025) confirms eligibility for continuous outpatient telemetry in these scenarios.
Private Insurance Coverage
Major payers classify MCT as medically necessary under documented clinical indications:
- Aetna
- Anthem Blue Cross
- UnitedHealthcare
- Cigna
- Humana
Prior authorization is generally not required when supported by the medical record.
Patient FAQ
10–30 days depending on your physician's order.
Yes. Showering and swimming are allowed with the device.
Yes, latex-free with gentle adhesive options available.
Yes, rhythm data streams in real time to your care team.
Fully covered by Medicare and most private plans when medically necessary.
Contact & Onboarding
For Patients
Email: support@rhythmguardian.com
Service Regions
Currently Serving: CA, OR, NV, AZ
Status: Expanding nationwide
References
- Am J Cardiol (2020). Comparison of Diagnostic Yield Between Mobile Cardiac Telemetry and Extended Holter Monitoring.
- Heart Rhythm (2019). Time to Detection and Therapeutic Implications of Continuous Telemetry.
- JACC Clin Electrophysiol (2021). Clinical Impact of Continuous Telemetry on Management Decisions.
- JACC Heart Fail (2023). Impact of Digital Monitoring on Outcomes.
- MedCrave J Clin Cardiol Res (2022). Outpatient Cardiac Telemetry Monitoring for Early Discharge.
- Open Access J Cardiac Care (2023). Mobile Health Applications in Cardiac Care.
- Heart Rhythm Society (2023). Human Oversight ECG Monitors Outperform AI Monitoring. https://www.hrsonline.org/
- PMC7316129 (2020). Wearable Devices for Ambulatory Cardiac Monitoring. https://pmc.ncbi.nlm.nih.gov/articles/PMC7316129/
- Biotricity (2025). Game-Changing Role of Mobile Cardiac Telemetry in Heart Care. https://biotricity.com/
- Diagnostic & Interventional Cardiology (2021). Research Demonstrates Cost Savings with Mobile Cardiac Telemetry. https://www.dicardiology.com/
- CMS Coverage Article A59268 (2025). Mobile Cardiac Telemetry Coverage Criteria. https://www.cms.gov/